Extra Strength Pain Relief
- Product NDC
- 57896-201
- 11-digit product format
- 578960201
- Labeler code
- 57896
- Product ID
- 57896-201_4525a8f8-b8bd-c290-e063-6394a90a81d9
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Geri-Care Pharmaceutical Corp
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 1989-01-01
- Marketing end
- 2026-11-30
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 57896-201 | 57896-201-01 | D | Discontinued by firm | 2026-10-15 | |
| excluded package | package | 57896-201 | 57896-201-05 | D | Discontinued by firm | 2026-10-15 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 57896-201-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 57896-201-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 57896-201-05 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 57896-201-01 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 57896-201-05 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 57896-201-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 57896-201-05 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 57896-201-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 57896-201-05 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 57896-201-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 57896-201-05 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 57896-201-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 57896-201-05 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 57896-201-01 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 57896-201-05 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 57896-201-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 57896-201-05 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 57896-201-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 57896-201-05 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 57896-201-01 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 57896-201-05 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 57896-201-01 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 57896-201-05 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 57896-201-01 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Extra Strength Pain Relief
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 198440 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7570aaa2-3238-4cd3-b788-915caa970dba | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57896-201-01 | Extra Strength Pain Relief | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 57896-201-05 | Extra Strength Pain Relief | 50 in 1 BOTTLE | TABLET | 50 | 7 | |
| 57896-201-10 | Extra Strength Pain Relief | 1000 in 1 BOTTLE | TABLET | 1000 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57896-201-01 | EA - Each | 57896-201 | 82dbdfae-7cce-45e7-bf0c-c214686bb896 | 1 | 2012-07-24 |
| 57896-201-05 | EA - Each | 57896-201 | 5d0770cd-70c2-4757-896d-62e868f751c0 | 1 | 2022-06-06 |
| 57896-201-10 | EA - Each | 57896-201 | aa5f4c60-e670-45f2-861b-c2ad8e686e2a | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Relief Extra Strength | ACETAMINOPHEN | DISCOUNT DRUG MART | e6fee238-0b6f-cb84-e053-2995a90a361b | 2024-12-05 | Warnings | M013 |
| Menstrual Complete Maximum Strength | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | L.N.K. International, Inc. | 379ef03c-3b6a-40c3-b736-99f0537d26c8 | 2024-12-05 | Warnings | M013 |
| Pain Reliever Extra Strength | ACETAMINOPHEN | Marc Glassman, Inc. | 43bf297f-2832-424f-a013-4bfa1d6c03e6 | 2024-12-04 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Precision Dose, Inc. | 5a68ab98-720c-479a-a60a-4e594add6c09 | 2024-12-04 | Warnings | M013 |
| HEB Effervescent Pain Relief | ASPIRIN | H. E. BUTT GROCERY COMPANY | 03876c71-60ec-3280-e063-6294a90a62dc | 2024-12-03 | Warnings | M013 |
| Migrafein FORTE | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 028875c9-4129-ce2c-e063-6294a90a26cc | 2024-12-03 | Warnings | M013 |
| Neo-Lubrina Fuerte | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 0288a327-fd4b-1991-e063-6294a90ace50 | 2024-12-03 | Warnings | M013 |
| CAFIZETAMOL FORTE | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 028771d3-a514-f7a5-e063-6394a90ac4f3 | 2024-12-03 | Warnings | M013 |
| Buscapina | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | OPMX LLC | 048c4b03-1cf4-b724-e063-6294a90a1cad | 2024-12-03 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN | TopCo Associates LLC | ecd6df7e-e7e2-446b-85ef-25971281fe31 | 2024-12-03 | Warnings | M013 |
| Market Basket Effervescent Pain Relief | ASPIRIN | DEMOULAS SUPER MARKETS, INC. | 08133bf0-3c8f-e4d0-e063-6294a90af79a | 2024-12-03 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | WinCo Foods, LLC | 4359da13-e851-440b-91b9-6b544bff20d2 | 2024-12-03 | Warnings | M013 |
| Low Dose Aspirin | ASPIRIN | WinCo Foods, LLC | 5b3e8a78-5357-42ad-811e-b2578b25dc7b | 2024-12-03 | Warnings | M013 |
| Low Strength Chewable Aspirin | ASPIRIN | Geri-Care Pharmaceutical Corp | cc77b9d1-7874-4ce8-a763-3a0e1c2891de | 2024-12-03 | Warnings | M013 |
| Good Sense Childrens Pain and Fever | ACETAMINOPHEN | L. Perrigo Company | c6b79501-d08b-4430-9545-70da5f545975 | 2024-12-03 | Warnings | M013 |
| Aspirin | ASPIRIN | Chain Drug Marketing Association | 0e3be5f4-bc1b-4b44-a86a-ace89f6ee592 | 2024-12-02 | Warnings | M013 |
| St. Joseph Chewable Low Dose Aspirin | ASPIRIN | Foundation Consumer Healthcare LLC | 248cd302-e380-4837-bdae-9df620b67e8a | 2024-12-02 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | AAA Pharmaceutical, Inc. | 2d98e390-4f2a-41cc-b307-3d2f6a3700dd | 2024-12-02 | Warnings | M013 |
| Acetaminophen PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | AAA Pharmaceutical, Inc. | 409b5fcd-5880-4dda-85d8-26aeceb4f8ab | 2024-12-02 | Warnings | M013 |
| Aspirin | ASPIRIN | AAA Pharmaceutical, Inc. | c0c31523-c4c5-43c2-8d72-4d1456c720e9 | 2024-12-02 | Warnings | M013 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 57896-201-01 | 57896020101 | 100 TABLET in 1 BOTTLE (57896-201-01) | 100 tablet | 2012-01-01 | 0000-00-00 | No | No | Current |
| 57896-201-05 | 57896020105 | 50 TABLET in 1 BOTTLE (57896-201-05) | 50 tablet | 2012-01-01 | 0000-00-00 | No | No | Current |
| 57896-201-10 | 57896020110 | 1000 TABLET in 1 BOTTLE (57896-201-10) | 1000 tablet | 2012-01-01 | 2026-11-30 | No | No | Current |
| 57896-201-20 | 57896020120 | 1 TABLET in 1 BOTTLE (57896-201-20) | 1 tablet | 2022-11-01 | 0000-00-00 | No | No | Current |